Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GORE VIABAHN Endoprosthesis Versus Bare Nitinol Stent in the Treatment of Long Lesion (>8cm) Superficial Femoral Artery Occlusive Disease

NCT00228384 is registered in ClinicalTrials.gov with W.L.Gore & Associates as lead sponsor.

NCT NCT00228384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00228384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GORE VIABAHN Endoprosthesis Versus Bare Nitinol Stent in the Treatment of Long Lesion (>8cm) Superficial Femoral Artery Occlusive Disease
Lead sponsor
W.L.Gore & Associates
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2005
Completion date
January 31, 2011
Enrollment
148 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral vascular diseases